APA (7th ed.) Citation

Callahan, A., & Hennerici, M. G. (2011). Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: Secondary analysis of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial. Archives of neurology, 68(10), .

Chicago Style (17th ed.) Citation

Callahan, Alfred, and Michael G. Hennerici. "Risk of Stroke and Cardiovascular Events After Ischemic Stroke or Transient Ischemic Attack in Patients with Type 2 Diabetes or Metabolic Syndrome: Secondary Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial." Archives of Neurology 68, no. 10 (2011).

MLA (9th ed.) Citation

Callahan, Alfred, and Michael G. Hennerici. "Risk of Stroke and Cardiovascular Events After Ischemic Stroke or Transient Ischemic Attack in Patients with Type 2 Diabetes or Metabolic Syndrome: Secondary Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial." Archives of Neurology, vol. 68, no. 10, 2011.